Recent news on

WORLD NOTES  -  25 May 2007
People's Weekly WorldThailand stopped buying Efavirenz made by Merck Sharp and Dohme, and Kaletra made by Abbott Laboratories. On May 14, Brazil followed suit by announcing

Govt considers revoking compulsory licence for Efavirenz  -  May 23, 2007
Bangkok Post,The government is considering revoking the compulsory licence issued for a generic version of the HIV/Aids medicine Efavirenz after a promising start to

Christian Aid partners back Brazil decision to defy US drugs giant  -  May 24, 2007
Reuters AlertNet,Brazil has followed Thailand's lead in importing a much cheaper generic version of the drug Efavirenz after negotiations with Merck over a price reduction

Brazil issues compulsory license on efavirenz  -  May 7, 2007
Aidsmap,The Brazilian government issued a compulsory license last Friday allowing the import of generic versions of efavirenz, after the drug’s patent holder Merck

Brazil bypasses Merck-patent on AIDS drug Efavirenz  -  May 4, 2007
People's Daily Online,With the decree, Brazil will be able to import generic versions of Efavirenz from three companies in India, and the price for the drugs will be 72 percent

Brazil Breaks Patent on Merck's Efavirenz AIDS Drug (Update1)  -  May 4, 2007
BloombergMay 4 (Bloomberg) -- Brazilian President Luiz Inacio Lula da Silva broke the patent on Merck & Co's AIDS drug Efavirenz after the company's offer to cut

Brazil Declares Merck's Efavirenz Drug of `Public Interest'  -  Apr 25, 2007
Bloomberg...s AIDS drug Efavirenz of ``public interest,'' a possible first step to breaking its patent protection, the Health Ministry said.

BRAZIL ISSUES COMPULSORY LICENCE FOR AIDS DRUG  -  May 10, 2007
International Centre for Trade and Sustainable Development,Brazil issued a compulsory licence for the patented AIDS drug efavirenz, in a move that has drawn reactions among public health and industry representatives

Human rightspanel warns Washington on trade curbs  -  May 18, 2007
Bangkok Post,US pharmaceutical giant Merck is the patent holder for Efavirenz, while Kaletra's patent belongs to Abbott Laboratories, also an American firm.

Indian firms to benefit  -  May 6, 2007
Business Standard,The Brazilian government’s decision to override the patent rights of Merck’s HIV/AIDS drug Stocrin (efavirenz) and buy reverse engineered generic versions

Brazilian Health Ministry Rejects Merck's Offer To Sell ...  -  May 8, 2007
Medical News Today (press release),Officials from the Brazilian Ministry of Health have rejected Merck's offer to sell its antiretroviral Efavirenz at a 30% discount in the country,

Brazil breaks patent on HIV/AIDS drug  -  May 8, 2007
SciDev.net,Brazilian president Luiz Inácio Lula da Silva signed a decree last week (4 May) issuing compulsory licensing for the HIV/AIDS drug efavirenz,

GlaxoSmithKline, Brazil Expected To Sign Deal on Providing ...  -  May 11, 2007
MedIndia,Merck sells Efavirenz for $1.80 per daily dose in most middle-income countries. A generic version of the drug would save Brazil about $240 million by 2012,

Brazil bypasses patent on HIV treatment  -  May 6, 2007
Business Day,Talks over the price of Merck’s drug, Efavirenz, broke off on Thursday when the health ministry rejected the New Jersey-based company’s offer to cut its $1

BRAZIL: Brazil to break Aids drug patent  -  May 8, 2007
CorpWatch.org,He said that the compulsory licensing of Efavirenz was a legitimate and necessary measure to guarantee that all patients had access to the drug.

Full Text  -  May 10, 2007
Science Magazine (subscription)Efavirenz is used by nearly 65000 of the 170000 people in Brazil now receiving free treatment from the government. Merck offered earlier in the week to cut

Brazil Moves Toward Breaking Drug Patent  -  May 3, 2007
Forbes,The official government news agency Radiobras reported Thursday that a government lab could produce efavirenz at 40 percent less than drug company's

Brazil Moves Toward Breaking Drug Patent  -  May 3, 2007
Houston Chronicle,Last week, Health Minister Jose Gomes Temporao declared Merck's efavirenz anti-retroviral drug a "public interest" medicine, a move that effectively gave

Brazil to Bypass AIDS Drug Patent  -  May 4, 2007
WTOP,Silva issued a "compulsory license" that would bypass Merck's patent on the AIDS drug efavirenz, a day after the Brazilian government rejected Merck's offer

A new trend in emerging nations - Brazil opts for Indian generic ...  -  May 6, 2007
India Daily,Brazilian president Luiz Inacio Lula da Silva has allowed his country to ignore US pharmaceutical giant Merck’s patent on AIDS drug Efavirenz and opted for

Brazil Takes Steps To Import Cheaper AIDS Drug Under Trade Law  -  May 7, 2007
Intellectual Property Watch,The product in question is the HIV/AIDS drug, efavirenz (Stocrin), marketed by Merck, and currently used by 38 percent of AIDS patients in Brazil as part of

Brazil bypasses patent on Merck AIDS drug  -  May 5, 2007
ReutersTalks over the price of Merck's drug, Efavirenz, broke off on Thursday when the health ministry rejected the New Jersey-based company's offer to cut its

BRAZIL DROPS MERCK DRUG  -  May 15, 2007
Free Market News Network,Brazil has announced that it will reject an offer by Merck to supply the antiviral drug Efavirenz, in favor of a generic drug supplier in India,

Brazil snubs US` Merck, for Indian drugs  -  May 5, 2007
Zee News,With a decree he signed on Friday, Brazil will be able to import generic versions of Efavirenz from three companies in India, and the price for the drugs

Brazil bypasses US giant for Indian drugs  -  May 5, 2007
India eNews.com,Brazilian President Luiz Inacio Lula da Silva has allowed his country to ignore US pharmaceutical giant Merck's patent on AIDS drug Efavirenz and opted for

Brazil Breaks Patent On A Merck Drug  -  May 8, 2007
Chemical & Engineering NewsLula acted shortly after the Brazilian government rejected Merck's offer to reduce its price for efavirenz, sold as Stocrin, from $1.59 per pill to $1.10.

Brazil Moves Toward Breaking Drug Patent  -  May 3, 2007
Forbes,Efavirenz is the most widely used medication by Brazil's anti-AIDS program, which provides free medicines for anyone who needs them.

Brazil breaks patent for AIDS medication  -  May 4, 2007
Earthtimes.orgThis decision affects the medication Efavirenz produced by US pharmaceutical company Merck Sharp & Dohme in the South American country.

Brazil Decides to Make Own AIDS Drug After Talks With Merck Collapse  -  May 3, 2007
Brazzil Magazine,In order for the Lafepe to start manufacturing the Efavirenz, the Health ministry declared the medicine to be of public interest, the first step for the

Brazil demands 60% efavirenz price cut, or may break patent  -  26 Apr 2007
Aidsmap,The decision came after efavirenz’s manufacturer Merck & Co refused to sell the drug to the Brazilian government at the same price recently agreed with the

Brazil Declares Merck's Efavirenz Drug of `Public Interest'  -  26 Apr 2007
Bloomberg...s AIDS drug Efavirenz of ``public interest,'' a possible first step to breaking its patent protection, the Health Ministry said.

Africa: Daily HIV/Aids Report  -  26 Apr 2007
AllAfrica.com,According to the decree, Efavirenz is a "public interest" medicine. Temporao at a news conference said the country did not issue the decree "as a threat,

Bristol-Myers Squibb Company Reports First Quarter 2007 Financial ...  -  26 Apr 2007
PharmaLive.com (press release),Total revenue for the SUSTIVA® Franchise includes sales of SUSTIVA® as well as revenue from bulk efavirenz included in the combination therapy ATRIPLA™,

Abbott, Thailand discuss options  -  Apr 24, 2007
Chicago Daily Herald,The post-coup government shocked pharmaceutical giants last November when it decided to override the patent on Efavirenz, an HIV-AIDS treatment made by

Speed of viral load decline is a sign of more effective ...  -  Apr 18, 2007
Aidsmap,A substudy of a large clinical trial has shown that viral load declined more quickly in people treated with AZT, 3TC and efavirenz (Sustiva) than in those

Strides Arcolab Receives Tentative FDA Approval For Efavirenz ...  -  Mar 30, 2007
Kaiser network.org,Efavirenz is the generic version of Bristol-Myers Squibb's Sustiva ( PTI/The Hindu , 3/28). The drug is used in combination therapies, as well as in drug

Strides Arcolab receives ANDA approval for Efavirenz tablet  -  Mar 28, 2007
Moneycontrol.com (press release),Strides Arcolab today announced that it has received tentative approval from the United States - Food and Drug Administration for Efavirenz tablets under

Strides Arcolab Gets Tentative US FDA Approval For Aids Drug Efavirenz  -  Mar 28, 2007
Trading Markets,...(RTTNews) - Wednesday, Strides Arcolab Ltd has announced that the company has received tentative approval from the US FDA for its Efavirenz tablets under

Strides Arcolab gets USFDA nod for efavirenz tablets  -  Mar 27, 2007
Myiris.com,Efavirenz, the generic version of Bristol Myers Squibb`s SUSTIVA, is a non nucleoside reverse transcriptase inhibitor which prevents the AIDS virus from

Africa: Daily HIV/Aids Report  -  Apr 16, 2007
AllAfrica.com,Thailand will maintain compulsory licenses for Abbott Laboratories' antiretroviral drug Kaletra and Merck's antiretroviral Efavirenz, despite both

South Africa: Nod for Aids Drugs is Cost Poser for State  -  Apr 25, 2007
AllAfrica.com,Talks were also under way with US-based Merck and Gilead for their three-in-one pill containing tenofovir, emtricitabine, and efavirenz, he said.

Thailand 'happy' with Abbott's price cut amid generic drug row  -  Apr 11, 2007
Nation Multimedia,Thailand's army-backed government has jolted the powerful pharmaceutical industry by allowing generic versions of Kaletra, another Aids drug Efavirenz,

Abbott Refuses Invitation for Second Round of Talks With Thai ...  -  Apr 10, 2007
Kaiser network.org,Merck Sharp & Dohme and Sanofi-Aventis, patent-holders of the antiretroviral Efavirenz and the heart disease drug Plavix, respectively, will attend the

Gilead's Atripla, Lower Costs Provide Lift To First Quarter  -  Apr 22, 2007
BioWorld Online,...s HIV compound Sustiva (efavirenz). Atripla sales added up to $190.2 million, a sequential increase of 38 percent from $137.4 million in the fourth quarter

Strides Arcolab gets US nod for anti-HIV drug  -  Mar 28, 2007
Economic Times,MUMBAI: Pharmaceutical company, Strides Arcolab has received tentative approval from the United States Food and Drug Administration (USFDA) for Efavirenz

Strides Arcolab gets USFDA nod for anti-HIV drug  -  Mar 27, 2007
Hindu,Efavirenz, is the generic version of Bristol Myers Squibb's 'Sustiva', which helps in preventing the HIV virus from reproduction.

Strides Arcolab gets US FDA nod for generic version of Bristol ...  -  Mar 28, 2007
Forbes,MUMBAI (AFX) - India's Strides Arcolab Ltd said it has received tentative approval from the US Food and Drug Administration for Efavirenz tablets,

Update: US envoy urges drug talks  -  Apr 23, 2007
Bangkok Post,In November, Dr Mongkol, as Thailand's Minister of Public Health, issued a compulsory licence for Merck's HIV/Aids treatment drug Efavirenz followed by the

Abbott Offers To Sell New Antiretroviral Drug Aluvia in Thailand ...  -  Apr 23, 2007
Kaiser network.org,...which the country currently is doing with generic versions of Merck's antiretroviral Efavirenz, despite the company's offer to reduce the drug's cost.

US envoy urges Thailand to talk with drug companies  -  Apr 23, 2007
Thai News Agency MCOT,In November, Dr. Mongkol, as Thailand's Minister of Public Health, issued a compulsory licence for Merck's HIV/Aids treatment drug Efavirenz followed by the

Dr Joseph Matare - HIV/AIDS Medical Officer - Namibia  -  Apr 23, 2007
ZimDaily,We either start with or substitute Nevirapine for Efavirenz or other drugs from other classes. Although TB and HIV have formed a formidable unholy alliance

Thailand Wins Concession on Drug  -  Apr 22, 2007
Wall Street Journal (subscription),Thailand still could choose to import generic drugs to replace Abbott's, however, just as it is now using generic versions of Merck's AIDS drug Efavirenz,

Abbott shuns Aids drug talks  -  Apr 9, 2007
Bangkok Post,He said, however, that representatives of MSD and Sanofi-Aventis, patent-holders of Efavirenz and the heart drug Plavix, are expected to attend the meeting.

The eight deadly lies of Big Pharma  -  Apr 20, 2007
Nation Multimedia,He neglects to mention that multiple generic versions of efavirenz manufactured in India have already received pre-qualification at the WHO.

Gilead Sciences Announces First Quarter 2007 Financial Results  -  Apr 19, 2007
PharmaLive.com (press release),This growth was driven primarily by Gilead's HIV product franchise, including the strong uptake of Atripla(TM) (efavirenz 600 mg/ emtricitabine 200 mg/

Gilead Sciences Announces First Quarter 2007 Financial Results  -  Apr 18, 2007
Business Wire (press release),This growth was driven primarily by Gilead’s HIV product franchise, including the strong uptake of Atripla™ (efavirenz 600 mg/ emtricitabine 200 mg/

Outcomes of paediatric antiretroviral treatment in resource ...  -  Apr 18, 2007
Aidsmap,...did not correlate with initial degree of immunosuppression, except that the profoundly immunosuppressed children were more likely to receive efavirenz.

Cost of new drugs must be stated  -  Apr 16, 2007
Bangkok Post,...the government announced a decision to adopt compulsory licensing for importing or producing copycat versions of costly Aids and heart drugs Efavirenz,

Comment: Drug makers forced to swallow ...  -  Apr 13, 2007
New Straits Times,Merck, the American drug maker, has also offered to cut the price of its HIV drug Efavirenz in Thailand after the Thai government announced last November

Narrative Review: Antiretroviral Therapy to Prevent the Sexual ...  -  Apr 16, 2007
Annals of Internal MedicineFirst-dose genital tract drug-exposure data are available for men who received tenofovir and efavirenz (34, 35) and for women who received 11 different

Gilead shifts Irish ops  -  Apr 13, 2007
BiopharmaReporter.com,Major products for the company include Atripla (efavirenz, emtricitabine, tenofovir), the only once-daily single tablet regimen for HIV-1 infection,

In the drug wars, Abbott blinks  -  Apr 12, 2007
Bangkok Post,Merck, the American drug maker, has also offered to cut the price of its HIV drug Efavirenz after the Thai government announced last November that it would

Thailand’s Bittersweet Victory over Big Pharma  -  Apr 12, 2007
Asia Sentinel,Indeed, Thailand’s recent moves to issue a compulsory license for Kaletra and other drugs — like Merck’s antiretroviral Efavirenz and Plavix,

Thailand to Push for More AIDS Drug Price Cuts  -  Apr 12, 2007
Reuters.uk,N: Quote, Profile , Research), announced a 46 percent reduction in the price of its HIV-AIDS drug, Efavirenz, for poor countries and those hit hard by the

Thailand to push for more AIDS drug price cuts  -  Apr 12, 2007
ReutersN: Quote, Profile, Research), announced a 46 percent reduction in the price of its HIV-AIDS drug, Efavirenz, for poor countries and those hit hard by the

This site is for informational purposes only--it does not offer medical advice or sell health products. If you need assistance, contact your physician or healthcare professional